Singapore markets close in 1 hour 9 minutes
Straits Times Index
3,301.11 +4.22 (+0.13%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,456.04 +248.91 (+1.37%) FTSE 100
8,192.97 +20.82 (+0.25%) Bitcoin USD
59,116.20 +1,487.88 (+2.58%) CMC Crypto 200
1,293.90 +16.92 (+1.33%)
ABT May 2024 118.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:03AM EDT. Market open.
| Previous close | 6.68 |
| Open | 6.68 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 118.00 |
| Expiry date | 2024-05-10 |
| Day's range | 6.68 - 6.68 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.